Karyopharm Therapeutics Inc. Payments for Royalties
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRoyalties · last filed 2026-08-13
- Karyopharm Therapeutics Inc. payments for royalties for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Karyopharm Therapeutics Inc. payments for royalties for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Karyopharm Therapeutics Inc. payments for royalties for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Karyopharm Therapeutics Inc. payments for royalties for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Karyopharm Therapeutics Inc. payments for royalties for fiscal 2025 was $3.71M, a 82.72% decline from fiscal 2024.
- Karyopharm Therapeutics Inc. payments for royalties for fiscal 2024 was $21.48M, a 33.78% increase from fiscal 2023.
- Karyopharm Therapeutics Inc. payments for royalties for fiscal 2023 was $16.05M, a 45.16% decline from fiscal 2022.
- Karyopharm Therapeutics Inc. payments for royalties for fiscal 2022 was $29.27M, a 182.53% increase from fiscal 2021.
| Period end | Payments for Royalties 3 month | Payments for Royalties 6 month | Payments for Royalties 9 month | Payments for Royalties 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $1.59M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $1.59M derived: sum of 3 quarters · filed 2026-08-13 | $3.71M 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.59M derived: sum of 2 quarters · filed 2026-08-13 | $3.71M 10-Q · filed 2025-11-03 | $6.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.71M 10-Q · filed 2026-08-13 | $6.26M derived: sum of 3 quarters · filed 2026-08-13 | $8.73M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.12M 10-Q · filed 2026-05-14 | $4.67M derived: sum of 2 quarters · filed 2026-05-14 | $7.14M derived: sum of 3 quarters · filed 2026-05-14 | $19.49M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.02M derived: sum of 2 quarters · filed 2026-02-13 | $17.37M derived: sum of 3 quarters · filed 2026-02-13 | $21.48M 10-K · filed 2026-02-13 |
| 2024-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $14.82M derived: sum of 2 quarters · filed 2025-11-03 | $18.93M 10-Q · filed 2025-11-03 | $22.75M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $12.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $16.45M 10-Q · filed 2025-08-11 | $20.28M derived: sum of 3 quarters · filed 2026-02-13 | $24.31M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $4.10M 10-Q · filed 2025-05-12 | $7.93M derived: sum of 2 quarters · filed 2026-02-13 | $11.96M derived: sum of 3 quarters · filed 2026-02-13 | $16.08M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $7.86M derived: sum of 2 quarters · filed 2026-02-13 | $11.98M derived: sum of 3 quarters · filed 2026-02-13 | $16.05M 10-K · filed 2026-02-13 |
| 2023-09-30 | $4.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $8.15M derived: sum of 2 quarters · filed 2024-11-05 | $12.22M 10-Q · filed 2024-11-05 | $16.54M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $4.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $8.19M 10-Q · filed 2024-08-06 | $12.51M derived: sum of 3 quarters · filed 2025-02-19 | $16.72M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $4.08M 10-Q · filed 2024-05-08 | $8.39M derived: sum of 2 quarters · filed 2025-02-19 | $12.60M derived: sum of 3 quarters · filed 2025-02-19 | $17.57M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $8.53M derived: sum of 2 quarters · filed 2025-02-19 | $13.49M derived: sum of 3 quarters · filed 2025-02-19 | $29.27M 10-K · filed 2025-02-19 |
| 2022-09-30 | $4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $9.18M derived: sum of 2 quarters · filed 2023-11-02 | $24.96M 10-Q · filed 2023-11-02 | $29.67M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $20.75M 10-Q · filed 2023-08-02 | $25.46M derived: sum of 3 quarters · filed 2024-02-29 | $27.04M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $15.78M 10-Q · filed 2023-05-04 | $20.50M derived: sum of 2 quarters · filed 2024-02-29 | $22.08M derived: sum of 3 quarters · filed 2024-02-29 | $23.69M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $6.29M derived: sum of 2 quarters · filed 2024-02-29 | $7.90M derived: sum of 3 quarters · filed 2024-02-29 | $10.36M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.19M derived: sum of 2 quarters · filed 2022-11-03 | $5.65M 10-Q · filed 2022-11-03 | $7.14M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.07M 10-Q · filed 2022-08-04 | $5.56M derived: sum of 3 quarters · filed 2023-02-17 | $7.68M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $2.46M 10-Q · filed 2022-05-05 | $3.95M derived: sum of 2 quarters · filed 2023-02-17 | $6.07M derived: sum of 3 quarters · filed 2023-02-17 | $7.23M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $3.61M derived: sum of 2 quarters · filed 2023-02-17 | $4.77M derived: sum of 3 quarters · filed 2023-02-17 | $6.01M 10-K · filed 2023-02-17 |
| 2020-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $3.28M derived: sum of 2 quarters · filed 2021-11-03 | $4.52M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.40M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.24M 10-Q · filed 2021-05-04 |